Allarity Therapeutics
ALLR
9 hedge funds and large institutions have $108K invested in Allarity Therapeutics in 2024 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, reducing their positions, and 0 closing their positions.
823% more capital invested
Capital invested by funds: $11.7K → $108K (+$96.1K)
350% more funds holding
Funds holding: 2 → 9 (+7)
0.07% more ownership
Funds ownership: 0% → 0.07% (+0.07%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$347K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$134K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$51.8K |
| 4 |
JF
Jump Financial
Chicago,
Illinois
|
+$50.7K |
| 5 |
HF
HRT Financial
New York
|
+$45.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$11 |
| 2 |
Morgan Stanley
New York
|
-$2 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VF
1
Virtu Financial
New York
| $56K | +$347K | +8,845 | New |
|
|
2
Geode Capital Management
Boston,
Massachusetts
| $21.8K | +$134K | +3,411 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $8.78K | +$51.8K | +1,319 | +2,398% |
|
|
JF
4
Jump Financial
Chicago,
Illinois
| $8.26K | +$50.7K | +1,293 | New |
|
|
HF
5
HRT Financial
New York
| $7K | +$45.4K | +1,156 | New |
|
6
Jane Street
New York
| $3.33K | +$20.5K | +522 | New |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $2.59K | +$15.5K | +395 | +3,950% |
|
8
Bank of America
Charlotte,
North Carolina
| $31 | +$196 | +5 | New |
|
|
HT
9
Headlands Technologies
Chicago,
Illinois
| $4 | +$39 | +1 | New |
|
|
10
Morgan Stanley
New York
| – | -$2 | – | – |
|
|
11
Wells Fargo
San Francisco,
California
| – | -$11 | – | – |
|
ALLR Hedge Fund Activity: Q2 2024 in Review
9 of the 6,930 institutional investors tracked by Wall St. Rank reported a position in Allarity Therapeutics (ALLR) for Q2 2024, worth a combined $108K — up 823% from $11.7K a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new ALLR positions and 0 closed out — a net gain of 7 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $347K. The largest seller was Wells Fargo, cutting an estimated $11.
- 9 institutional investors held Allarity Therapeutics (ALLR) as of Q2 2024, up from 2 in Q1 2024.
- Funds reported $108K of Allarity Therapeutics stock for Q2 2024, up 823% quarter-over-quarter.
- 7 funds opened new Allarity Therapeutics positions in Q2 2024 and 0 closed out, a net change of +7 holders.
- The largest Allarity Therapeutics buyer in Q2 2024 was Virtu Financial, an estimated $347K added.
- The largest Allarity Therapeutics seller in Q2 2024 was Wells Fargo, an estimated $11 sold.
Based on aggregated 13F filings for Q2 2024.